Lv61
2550 积分 2022-04-01 加入
New treatment strategies for advanced-stage gastrointestinal stromal tumours
1个月前
已完结
Guidelines for Diagnosis, Indications for Treatment, Response Assessment, and Supportive Management of Chronic Lymphocytic Leukemia: The 2018 Update
2个月前
已完结
Maintenance therapy for chronic lymphocytic leukaemia
3个月前
已完结
Chronic myeloid leukemia: 2025 update on diagnosis, therapy, and monitoring
3个月前
已完结
Updates in Biology, Classification, and Management of Acute Myeloid Leukemia with Antecedent Hematologic Disorder and Therapy Related Acute Myeloid Leukemia
3个月前
已完结
Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study
11个月前
已完结
Novel BCL-2 Inhibitor Lisaftoclax in Relapsed or Refractory Chronic Lymphocytic Leukemia and Other Hematologic Malignancies: First-in-Human Open-Label Trial
1年前
已完结
Second Autologous Stem Cell Transplant as Salvage in Multiple Myeloma – The Oregon Health and Science University Experience
1年前
已完结
Second stem cell transplantation for treatment of relapsed/refractory multiple myeloma after first autologous stem cell transplant: A 15-year retrospective institutional analysis
1年前
已完结
Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 study
1年前
已完结
皖公网安备34019202002308
